June 18, 2013 – Last September, mesothelioma attorney Bob Komitor, a partner at Levy Konigsberg LLP, was a featured as asbestos litigation expert at an NYC mesothelioma conference where he shared the stage with prominent oncologists, surgeons, and other medical experts in the area of mesothelioma cancer.
LAST SEPTEMBER, MESOTHELIOMA ATTORNEY BOB KOMITOR, A PARTNER AT LEVY KONIGSBERG LLP, WAS A FEATURED AS ASBESTOS LITIGATION EXPERT AT AN NYC MESOTHELIOMA CONFERENCE WHERE HE SHARED THE STAGE WITH PROMINENT ONCOLOGISTS, SURGEONS, AND OTHER MEDICAL EXPERTS IN THE AREA OF MESOTHELIOMA CANCER.
Mesothelioma attorney Bob Komitor (second from right) with (from left to right) Lee Krug, M.D., Mary Hesdorffer, N.P., and Richard Mosca.
NEW YORK, New York, June 18, 2013 – For those whose lives have been affected by mesothelioma, it may sometimes seem that this asbestos-related cancer is overlooked in the medical and research communities. However, on September 28, 2012, the Harvard Club in New York City was host to some of the brightest minds in mesothelioma treatment, research, and law. The one-day conference, called “Knowledge Is Hope,” provided a forum for patients, their families, doctors, and others wishing to learn more about this rare disease. The conference was supported by an educational grant from Levy Konigsberg LLP (“LK”), one of the nation’s premier law firms representing mesothelioma patients and their families. LK partner and mesothelioma attorney, Bob Komitor was a featured legal expert at the conference.
One of the speakers was Lee Krug, MD, whose primary responsibility as a thoracic oncologist at Memorial Sloan-Kettering is to care for patients with lung cancer and malignant pleural mesothelioma. He also runs clinical trials that test novel drugs and treatment strategies for individuals with small cell lung cancer and mesothelioma. He has a particular interest in therapies that boost the immune system to allow it to recognize and attack specific molecules on cancer cells. He has conducted studies testing cancer vaccines developed by scientists in patients with small-cell lung cancer and mesothelioma.
At the conference, Dr. Krug discussed the current state of mesothelioma treatments as well as new therapies in development, including the possibility of clinical trials for angiogenesis inhibitors and anti-VEGF antibodies for mesothelioma within the next 1 to 2 years. See Dr. Krug speak here.
Also, present were members of the Mesothelioma Applied Research Foundation, the non-profit that organized the conference. MARF is the national organization dedicated to finding a cure and eradicating mesothelioma as a life-ending disease by (1) funding the highest quality and most promising mesothelioma research projects from around the world through their rigorous peer-reviewed process; (2) helping mesothelioma patients connect with national mesothelioma experts and obtain the most up-to-date information on treatment options; and (3) advocating in Washington D.C. for federal mesothelioma research funding to stop this national tragedy.
LK mesothelioma attorneys (2nd and 3rd from left) Audrey Perlman Raphael and John P. Guinan with conference attendees.
MARF’s first speaker was Mary Hesdorffer, NP. Ms. Hesdorffer, an Executive Director of MARF, discussed the latest advances in treatment options for mesothelioma. She noted that results from early-stage clinical trials show a future of promising treatments, including the MORAb-009 antibody that targets mesothelin and the CBP501 compound. See Ms. Hesdorffer speak here.
MARF’s second speaker was Hannie Mintz, co-chair of the Meso Foundation Board of Directors. She discussed the foundation’s goals to find effective treatment and ultimately a cure for mesothelioma. She recommended both physicians and patients contact the Meso Foundation for the latest developments in mesothelioma research. See Ms. Mintz speak here.
Representing the legal community at the conference was mesothelioma attorney Bob Komitor, a partner at LK. He discussed the best way for mesothelioma patients to receive compensation. Asbestos exposure is the only known and well-recognized cause of mesothelioma, making the disease highly preventable. Patients should speak to qualified mesothelioma lawyers to determine a history of potential exposures. See Mr. Komitor speak here.
Special thanks go to The Doctor’s Channel for donating its time and resources to help bring mesothelioma awareness to a broader spectrum of the medical community. TDC offers free, online video CME, medical news, and physician education. It features insights and opinions from experts in over 50 specialties, as well as community and lifestyle features that help doctors stay on top of the latest news, ideas, and information.
For over a quarter of a century, mesothelioma lawyers at Levy Konigsberg LLP have been among the pioneers of asbestos litigation in America. The firm’s attorneys have been recognized as nationwide leaders in representing the rights of mesothelioma victims and their families. Their clients have received some of the largest mesothelioma compensation verdicts in the country.
For more information about this or other mesothelioma lawsuits, please contact Levy Konigsberg LLP at (800) 315-3806 or 1-800-MESO-LAW (1-800-637-6529), 24 hours a day, 7 days a week.